It seems that everyone is looking for the newest molecule, the newest therapy, the newest technique that will halt the progression of Duchenne. This is good and we should continue on this journey. But none of these novel treatments will get to patients without first going through a rigorous evaluation in clinical trials.
Asking the Right Questions
First we have to ask the big questions:
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this